FindTrial
Sign In

High-flow nasal cannula oxygen therapy during endotracheal intubation in patients at high altitude

High-flow nasal cannula oxygen therapy during endotracheal intubation in patients at high altitude: a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100045562
Enrollment
Unknown
Registered
2021-04-19
Start date
2021-04-26
Completion date
Unknown
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypoxemia

Interventions

1 group:High flow nasal cannula oxygen therapy
2 group:Beg mask oxygenation

Sponsors

People's Hospital of the Tibet Autonomous Region
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Adult patients (over 18 years old) undergoing elective tracheal intubation under general anesthesia.

Exclusion criteria

Exclusion criteria: 1. Patients with high risk of reflux aspiration (emergency department, pregnant women, gastroesophageal reflux, etc.); 2. Patients who cannot wear the face or upper respiratory tract trauma; 3. Severely blocked nasal cavity.

Design outcomes

Primary

MeasureTime frame
Incidence of hypoxemia;—

Secondary

MeasureTime frame
Lowest oxygen saturation;Preoperative oxygen saturation at room air;Oxygen saturation after preoxygenation;Oxygen saturation 5 minutes after endotracheal intubation;Tracheal intubation duration;Tracheal intubation times;Tracheal intubation complications;—

Countries

China

Contacts

Public ContactQuan Xiang

Peking Union Medical College Hospital, People's Hospital of the Tibet Autonomous Region

quan79102@188.com+86 13683658102

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026